FDA NDC Directory · JSON-LD · Markdown

XGEVA

NDC 55513-730 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedenosumab
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA125320
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (120 mg/1.7mL)
Marketing started20101118
Package count2

External sources

Source: openFDA. Public-domain (CC0).